Skip to main content


Fig. 1 | Radiation Oncology

Fig. 1

From: Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience

Fig. 1

LPFS depends significantly on the use of concomitant systemic therapy with survival benefit for patients receiving cisplatin weekly chemotherapy vs. others (carboplatin/5-fluoruracil and cetuximab) (p = 0.006). 5-year LPFS amounts 86% vs. 43% for patients who received concomitant cisplatin weekly vs. patients who did not

Back to article page